For Immediate Assistance Call 1-800-966-2244
Mesothelioma Asbestos Mesothelioma Resources Mesothelioma Attorneys Mesothelioma Settlements Mesothelioma Claims

Detecting Abnormal Cells in Patients Surgery for Lung Cancer

This phase I trial is studying how well optical coherence tomography of the airway works in detecting abnormal cells in patients undergoing surgery for lung cancer or lung disease. Diagnostic procedures, such as optical coherence tomography, may help find and diagnose lung cancer or precancerous cells.

  • Start Date: April 2008
  • Primary Completion Date: January 2010
  • Completion Date:
  • Last Updated Date: June 9, 2010

Disease Characteristics

  • Undergoing pneumonectomy or lobectomy for malignant or benign lung processes

Patient Characteristics

  • Not specified

Prior Concurrent Therapy

  • See Disease Characteristics

Please refer to this study by its ClinicalTrials.gov identifier: NCT00733252.

For More Information On How You Can Participate In This Clinical Trial

  • Ireland Cancer Center at University Hospitals Case Medical Center Cleveland, Ohio 44106
  • Geauga Regional Hospital Cleveland, Ohio 44024
  • Lake/University Ireland Cancer Center Cleveland, Ohio 44060
  • Mercy Cancer Center at Mercy Medical Center Cleveland, Ohio 44708
  • Southwest General Health Center Cleveland, Ohio 44130
  • UHHS Chagrin Highlands Medical Center Cleveland, Ohio 44122
  • UHHS Westlake Medical Center Cleveland, Ohio 44145
  • University Suburban Health Center Cleveland, Ohio 44121

Find More Information on